After three years,
Rexam inaugurated its new Bangalore plant on May 14. Rexam Pharma’s
new India facility is designed around a state-of-the-art, 1,000 sq.
meter class 8 cleanroom that is fully compliant with cGMP standards
and brings to India new technologies such as child-resistant closures
and its internationally renowned Rispharm range for ophthalmology.
Rexam Pharma is
also replicating its successful development model by opening a new
Technology Center in Bangalore to support pharmaceutical companies
with strong design, development and industrialization expertise as
well as regulatory support for all pharmaceutical packaging
requirements.
As the first
multinational company in its field to have a fully owned subsidiary in
India, Rexam Pharma already supports local and multinational partners
in their product development, offering high quality products for all
routes of administration.
Rexam is
headquartered in London, UK. The company has 100 plants in more than
20 countries. For more information, visit
www.rexam.com.